TLDR
- Palantir stock rose 2.3% pre-market to $131.05 on Monday, April 13.
- President Trump praised the company on Truth Social, calling it a proven “war fighting” tool.
- Cathie Wood’s ARK Invest bought 85,485 PLTR shares across five ETFs, worth around $10.95–$11.15 million.
- The ARKK ETF led the purchase with 46,455 shares; ARKQ, ARKW, ARKF, and ARKX also added positions.
- Despite the bounce, PLTR is still down 28% in 2026 and trades at 99x expected 2026 earnings.
Palantir stock got a lift Monday morning from two familiar forces: a presidential endorsement and a big bet from Cathie Wood.
The stock was up 2.3% pre-market, hitting $131.05 ahead of the opening bell. That came against a weak broader market backdrop — S&P 500 futures were down 0.6% as Trump’s order for the U.S. Navy to form a blockade in the Strait of Hormuz rattled investors.
Palantir Technologies Inc., PLTR
On Friday, Trump posted on Truth Social: “Palantir Technologies (PLTR) has proven to have great war fighting capabilities and equipment. Just ask our enemies!!!” The comment helped PLTR claw back some losses during a session already weighed down by investor nerves around Anthropic’s latest AI model.
It’s not the first time a Trump comment has moved the stock, and it likely won’t be the last.
ARK Invest Loads Up on PLTR
ARK Invest’s daily trade log for April 11 showed the firm bought 85,485 Palantir shares across five of its ETFs. The total value came in at roughly $10.95 to $11.15 million, depending on the price used.
The ARKK ETF took the largest slice with 46,455 shares. ARKQ added 15,127, ARKW picked up 11,865, ARKF grabbed 5,973, and ARKX took 6,065.
Wood has been a long-time Palantir bull. With the stock down sharply from its highs, this looks like ARK using the dip to add to an existing conviction position.
On the other side of the ledger, ARK sold 44,446 AMD shares worth around $10.52 million across the same ETFs. ARK also offloaded 75,389 shares of Strata Critical Medical (SRTA) for roughly $305,000, continuing a trend of exiting that position.
A Stock Under Pressure
For all the positive headlines, Palantir is still under real pressure in 2026. The stock has dropped 28% year-to-date, a steep fall from the highs it hit late last year.
The core question for investors is valuation. At 99 times expected 2026 earnings, the market is pricing in a lot of growth. Skeptics wonder whether Palantir can deliver that growth fast enough — especially with AI reshaping the software landscape it operates in.
That tension between strong government and defense demand and an expensive price tag has defined the stock’s story this year.
Monday’s pre-market move puts PLTR around $131.05. ARK’s purchase was made at Friday’s close, when the stock traded near $128.
🚨 Our April Stock Picks Are Live!
A new month means new opportunities. Our analysts have just released their top stock picks for April, highlighting companies with strong momentum that rank highly on our KO Score algorithm. We’re also now sharing trade ideas for both long-term and short-term investors, giving you more ways to spot potential opportunities in the market.
Sign up to Knockout Stocks today and get 50% off to unlock the full list and see which stocks made the cut.
Use coupon code Special50 for your exclusive discount!







